WVE logo

Wave Life Sciences Ltd. (WVE) EBITDA

Annual EBITDA:

-$101.74M-$42.95M(-73.06%)
December 31, 2024

Summary

  • As of today, WVE annual EBITDA is -$101.74 million, with the most recent change of -$42.95 million (-73.06%) on December 31, 2024.
  • During the last 3 years, WVE annual EBITDA has risen by +$15.44 million (+13.18%).
  • WVE annual EBITDA is now -2984.90% below its all-time high of -$3.30 million, reached on December 31, 2013.

Performance

WVE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEincome statement metrics

Quarterly EBITDA:

-$50.56M-$2.92M(-6.14%)
June 30, 2025

Summary

  • As of today, WVE quarterly EBITDA is -$50.56 million, with the most recent change of -$2.92 million (-6.14%) on June 30, 2025.
  • Over the past year, WVE quarterly EBITDA has dropped by -$17.74 million (-54.04%).
  • WVE quarterly EBITDA is now -301.26% below its all-time high of $25.12 million, reached on December 31, 2024.

Performance

WVE Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEincome statement metrics

TTM EBITDA:

-$134.84M-$17.74M(-15.15%)
June 30, 2025

Summary

  • As of today, WVE TTM EBITDA is -$134.84 million, with the most recent change of -$17.74 million (-15.15%) on June 30, 2025.
  • Over the past year, WVE TTM EBITDA has dropped by -$59.94 million (-80.03%).
  • WVE TTM EBITDA is now -10575.93% below its all-time high of -$1.26 million, reached on September 30, 2014.

Performance

WVE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

WVE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-73.1%-54.0%-80.0%
3Y3 Years+13.2%-27.5%-18.3%
5Y5 Years+48.9%-39.8%+20.8%

WVE EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-73.1%+33.3%-301.3%+18.1%-129.3%+11.6%
5Y5-Year-73.1%+48.9%-301.3%+18.1%-129.3%+20.8%
All-TimeAll-Time-2984.9%+48.9%-301.3%+18.1%>-9999.0%+32.3%

WVE EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$50.56M(-6.1%)
-$134.84M(-15.1%)
Mar 2025
-
-$47.64M(-289.6%)
-$117.10M(-15.1%)
Dec 2024
-$101.74M(-73.1%)
$25.12M(+140.7%)
-$101.74M(+29.0%)
Sep 2024
-
-$61.76M(-88.1%)
-$143.36M(-91.4%)
Jun 2024
-
-$32.83M(-1.7%)
-$74.90M(-18.5%)
Mar 2024
-
-$32.28M(-95.6%)
-$63.22M(-7.5%)
Dec 2023
-$58.79M(+61.5%)
-$16.50M(-346.0%)
-$58.79M(+29.5%)
Sep 2023
-
$6.71M(+131.7%)
-$83.36M(+34.0%)
Jun 2023
-
-$21.15M(+24.0%)
-$126.36M(+12.8%)
Mar 2023
-
-$27.85M(+32.2%)
-$144.87M(+5.1%)
Dec 2022
-$152.61M(-30.2%)
-$41.07M(-13.1%)
-$152.61M(-5.2%)
Sep 2022
-
-$36.30M(+8.5%)
-$145.11M(-27.3%)
Jun 2022
-
-$39.66M(-11.5%)
-$114.02M(-2.0%)
Mar 2022
-
-$35.58M(-6.0%)
-$111.75M(+4.6%)
Dec 2021
-$117.18M(+18.3%)
-$33.57M(-544.4%)
-$117.18M(-5.2%)
Sep 2021
-
-$5.21M(+86.1%)
-$111.41M(+19.3%)
Jun 2021
-
-$37.39M(+8.8%)
-$138.11M(-0.9%)
Mar 2021
-
-$41.01M(-47.5%)
-$136.89M(+2.2%)
Dec 2020
-$143.39M(+28.0%)
-$27.80M(+12.9%)
-$139.99M(+17.8%)
Sep 2020
-
-$31.91M(+11.8%)
-$170.29M(+10.5%)
Jun 2020
-
-$36.17M(+18.0%)
-$190.21M(+3.6%)
Mar 2020
-
-$44.11M(+24.1%)
-$197.40M(+0.9%)
DateAnnualQuarterlyTTM
Dec 2019
-$199.12M(-29.3%)
-$58.10M(-12.1%)
-$199.12M(-5.8%)
Sep 2019
-
-$51.82M(-19.5%)
-$188.24M(-8.7%)
Jun 2019
-
-$43.37M(+5.4%)
-$173.19M(-4.9%)
Mar 2019
-
-$45.82M(+3.0%)
-$165.17M(-7.3%)
Dec 2018
-$153.94M(-53.6%)
-$47.23M(-28.4%)
-$153.94M(-12.4%)
Sep 2018
-
-$36.77M(-4.1%)
-$136.98M(-8.7%)
Jun 2018
-
-$35.34M(-2.1%)
-$125.97M(-9.6%)
Mar 2018
-
-$34.60M(-14.3%)
-$114.94M(-14.7%)
Dec 2017
-$100.24M(-82.5%)
-$30.27M(-17.5%)
-$100.24M(-13.6%)
Sep 2017
-
-$25.76M(-5.9%)
-$88.21M(-11.0%)
Jun 2017
-
-$24.32M(-22.2%)
-$79.50M(-19.3%)
Mar 2017
-
-$19.89M(-9.0%)
-$66.64M(-22.2%)
Dec 2016
-$54.94M(-193.7%)
-$18.25M(-7.0%)
-$54.54M(-25.7%)
Sep 2016
-
-$17.05M(-48.8%)
-$43.38M(-39.8%)
Jun 2016
-
-$11.45M(-46.9%)
-$31.04M(-34.2%)
Mar 2016
-
-$7.80M(-10.1%)
-$23.13M(-23.6%)
Dec 2015
-$18.70M(-265.8%)
-$7.08M(-50.5%)
-$18.70M(-40.5%)
Sep 2015
-
-$4.71M(-32.9%)
-$13.32M(-34.9%)
Jun 2015
-
-$3.54M(-4.9%)
-$9.87M(-55.9%)
Mar 2015
-
-$3.38M(-99.3%)
-$6.33M(-114.2%)
Dec 2014
-$5.11M(-55.0%)
-$1.69M(-34.1%)
-$2.96M(-134.1%)
Sep 2014
-
-$1.26M
-$1.26M
Dec 2013
-$3.30M
-
-

FAQ

  • What is Wave Life Sciences Ltd. annual EBITDA?
  • What is the all-time high annual EBITDA for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. annual EBITDA year-on-year change?
  • What is Wave Life Sciences Ltd. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. quarterly EBITDA year-on-year change?
  • What is Wave Life Sciences Ltd. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. TTM EBITDA year-on-year change?

What is Wave Life Sciences Ltd. annual EBITDA?

The current annual EBITDA of WVE is -$101.74M

What is the all-time high annual EBITDA for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high annual EBITDA is -$3.30M

What is Wave Life Sciences Ltd. annual EBITDA year-on-year change?

Over the past year, WVE annual EBITDA has changed by -$42.95M (-73.06%)

What is Wave Life Sciences Ltd. quarterly EBITDA?

The current quarterly EBITDA of WVE is -$50.56M

What is the all-time high quarterly EBITDA for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high quarterly EBITDA is $25.12M

What is Wave Life Sciences Ltd. quarterly EBITDA year-on-year change?

Over the past year, WVE quarterly EBITDA has changed by -$17.74M (-54.04%)

What is Wave Life Sciences Ltd. TTM EBITDA?

The current TTM EBITDA of WVE is -$134.84M

What is the all-time high TTM EBITDA for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high TTM EBITDA is -$1.26M

What is Wave Life Sciences Ltd. TTM EBITDA year-on-year change?

Over the past year, WVE TTM EBITDA has changed by -$59.94M (-80.03%)
On this page